Epidemiological study of diabetes mellitus in North India

  • Shailja Singh Department of Pathology, Institute of Medical Sciences, Banaras Hindu University, Varanasi, UP, India
  • Usha Singh Department of Pathology, Institute of Medical Sciences, Banaras Hindu University, Varanasi, UP, India
  • Neeraj Kumar Agrawal Department of Endocrinology, Institute of Medical Sciences, Banaras Hindu University, Varanasi, UP, India
  • Rana Singh Department of Nephrology, Institute of Medical Sciences, Banaras Hindu University, Varanasi, UP, India.
Keywords: Diabetes mellitus, Type 1 DM, symptom of DM, complication of DM

Abstract

Background: Diabetes mellitus is a chronic metabolic disease. Its prevalence increases every year. Aim of the present study was to see the clinical features of DM cases and to predict the prevalence of complication in both types of DM (T1DM and T2DM). Materials and Methods:Total 325 DM cases including 150 of T1DM and 175 of T2DM were taken from the OPD of Endocrinology and Nephrology, S.S. Hospital, BHU, Varanasi during the period 2012-2014. Data was collected from DM patients who were interviewed through a questionnaire. Data were analyzed using SPSS software. Results:In T1DM, age of onset of disease were 31.3% in < 14 years, 46.0% in 15-25 years and 22.7% cases in >25 years. However in T2DM, most of were diagnosed in age between 40-55 years of age. In all cases males were more affected than females in both types of DM. T1DM patients had lower BMI (18.64 ± 5.46). Weight loss, polyphagia, polyuria, abdominal pain and fever were significantly more in T1DM patients while weight gain was more in T2DM. Complication was significantly more seen in T2DM.Conclusion:Thus, we conclude that More than 75% cases of T1DM affected the patients in the age below 25 yrs, while in T2DM cases above the 40 Yrs age. Age, gender and BMI are important risk factor for DM cases.  T2DM was more affected by complication than T1DM. DOI:10.212276/AABS.1904

Author Biographies

Shailja Singh, Department of Pathology, Institute of Medical Sciences, Banaras Hindu University, Varanasi, UP, India
Shailja Singh is a Ph.D. Student in the Department of Pathology, Institute of Medical Sciences, Banaras Hindu University, Varanasi. She has published research papers in various journals and also presented various papers in national and international conferences.
Usha Singh, Department of Pathology, Institute of Medical Sciences, Banaras Hindu University, Varanasi, UP, India
Dr. Usha is a Professor in the Department of Pathology, Institute of Medical Sciences, Banaras Hindu University, Varanasi. She has published research papers in various journals and also presented various papers in national and international conferences.
Neeraj Kumar Agrawal, Department of Endocrinology, Institute of Medical Sciences, Banaras Hindu University, Varanasi, UP, India
Dr. Agrawal is a Professor in the Department of Endocrinology, Institute of Medical Sciences, Banaras Hindu University, Varanasi. He has published research papers in various journals and also presented various papers in national and international conferences.
Rana Singh, Department of Nephrology, Institute of Medical Sciences, Banaras Hindu University, Varanasi, UP, India.
Dr. Singh has been worked as an Ex-Professor in the Department of Nephrology, Institute of Medical Sciences, Banaras Hindu University, Varanasi. Currently he is working in the same department of Heritage Varanasi. He has published research papers in various journals and also presented various papers in national and international conferences.

References

1. International Diabetic Federation (IDF), IDF Diabetes Atlas Eighth Edition 2017; 8th ed:1-150.

2. American diabetic Association (ADA). Classification and Diagnosis of Diabetes. Diabetes Care. 2017;40(1):S11–S24.

3. Karvonen M, Tuomilehto J, Libman I. A review of the recent epidermiological data on the world wide incidence of the Type I (Insulin-dependent) diabetes mellitus. World Health Organizaion. Diamond Group. Diabetologia. 1993; 36:883-92.

4. Maitra A, The Endocrine System; Robbins And Cotran; Pathologic Basis Of Disease; 8ed; Chapter 24; 1857-1879; 2010.

5. DIAMOND Project Group, Incidence and trends of childhood Type 1 diabetes worldwide 1990–1999, Diabetic Medicine, 2006; 23(8): 857–866.

6. Laakso M, Pyorala K, Age of onset and type of diabetes, Diabetes Care. 1985 Mar-Apr;8(2):114-7.

7. EURODIAB ACE Study Group. Variation and trends in incidence of childhood diabetes in Europe. Lancet.2000;355:873-876.

8. Dabelea D, Bell RA, D’Agostino RB, et al. Incidence of diabetes in youth in the United States. JAMA.2007;297:2716-2724.

9. Neil HA, Gatling W, Mather HM, et al, The Oxford community Diabetes study; evidence for an increase in the prevalence of known diabetes in Great Britain. Diabetic Med, 1987 4:539-543.

10. Shaw JE, Sicree RA, Zimmet PZ, Diabetes Atlas:Global estimates of the prevalence of diabetes for 2010 and 2030, diabetes research and clinical practice , 2010; 87: 4 – 1 4.

11. Ramachandran A: Epidemiology of diabetes in India: three decades of research. J Assoc Phy India.2004;53:34–38.

12. Kalra S, Kalra B, Sharma A, Prevalence of type 1 diabetes mellitus in Karnal district, Haryana state, India, Diabetology & Metabolic Syndrome 2010, 2 (14):1-3.

13. Kautzky-Willer A, Harreiter J, Pacini G , Sex and Gender Differences in Risk, Pathophysiology and Complications of Type 2 Diabetes Mellitus, Endocr Rev, 2016 Jun; 37(3): 278–316.

14. Gorus FM, Weets L, Couck P Pipeleers DG, The Belgian Diabetes Registry, Epidemiology of type 1 and type 2 diabetes. The added value of diabetes registries for conducting clinical studies: The Belgian, Acta Clinica Belgica, 2004; 59-I:1-13.

15. Knowler WC, Pettitt DJ, Saad MF, et al. Obesity in the Pima Indians: its magnitude and relationship with diabetes. A J Clin Nutr 1991;53:S1543-S51.

16. Colditz GA, Willett WC, Stampfer MJ, et al. Weight as a risk factor for clinical diabetes in women. Am J Epidemiol.1990;132(3):501-13.

17. Vikram NK, Misra A, Dwivedi M, Sharma R, Pandey RM, Luthra K et al. Correlations of C-reactive protein levels with anthropometric profile, percentage of body fat and lipids in healthy adolescents and young adults in urban North India. Atherosclerosis. 2003;168(2):305–13.

18. Narayan KM, Boyle JP, Thompson TJ, et al. Lifetime risk for diabetes mellitus in the United States. JAMA.2003;290:1884-1890.

19. Logue J, Walker JJ, Leese G, et al. Association between BMI measured within a year after diagnosis of type 2 diabetes and mortality. Diabetes Care 2013;36:887-893.

20. Yoon PW, Scheuner MT, Peterson-Oehlke KL, Gwinn M, Faucett A, Khoury MJ. Can family history be used as a tool for public health and preventive medicine? Genet Med 2002;4:304–310.

21. Annis AM, Caulder MS, Cook ML, Duquette D. Family history, diabetes, and other demographic and risk factors among participants of the National Health and Nutrition Examination Survey 1999-2002. Preventing Chronic Disease: Public Health Research, Practice, and Policy. 2005 Apr:2(2):1–12.

22. Olmos P, A’Hern R, Heaton DA,The significance of the concordance rate for type 1 (insulin-dependent) diabetes in identical twins. Diabetologia. 1988 Oct;31(10):747-50.

23. Centers for Disease Control and Prevention (CDC), Awareness of family health history as a risk factor for disease--United States, 2004. MMWR Morb Mortal Wkly Rep. 2004 Nov 12;53(44):1044-7.

24. Raman R, Ganesan S, Pal SS, Kulothungan V, Sharma T. Prevalence and risk factors for diabetic retinopathy in rural India. Sankara Nethralaya Diabetic Retinopathy Epidemiology and Molecular Genetic Study III (SN-DREAMS III), report no 2. BMJ Open Diabetes Res Care 2014;2:e000005:1-8.

25. Chawla A, Chawla R, Jaggi S. Microvasular and macrovascular complications in diabetes mellitus: Distinct or continuum?. Indian journal of endocrinology and metabolism. 2016 Jul;20(4):546.

26. Adler AI, Stevens RJ, Manley SE, Bilous RW, Cull CA, Holman RR, UKPDS Group. Development and progression of nephropathy in type 2 diabetes: the United Kingdom Prospective Diabetes Study (UKPDS 64). Kidney international. 2003 Jan 31;63(1):225-32.

27. UK Prospective Diabetes Study (UKPDS). VIII. Study design, progress and performance. Diabetologia. 1991;34:877–890.

28. Dyck PJ, Davies JL, Wilson DM, et al. Risk factors for severity of diabetic polyneuropathy. Intensive longitudinal assessment of the Rochester Diabetic Neuropathy Study cohort. Diabetes Care. 1999;22:1479-1486.

29. Roche EF, Menon A, Gill D, Hoey H. Clinical presentation of type 1 diabetes, Pediatric Diabetes. 2005;6:75–78.

30. Al-Yaarubi S, Ullah I, Sharef SW, Al Shidhani A, Al Hanai S, Al Kalbani R, Al Jamoodi S. Demographic and clinical characteristics of type 1 diabetes mellitus in omani children-single center experience. Oman medical journal. 2014 Mar;29(2):119-22.
Published
2018-02-16
Section
Original Article